These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 1704216
1. Inhibition of nucleic acid synthesis in P388 lymphocytic leukemia cells in culture by cis-platinum derivatives. Oswald CB, Chaney SG, Hall IH. Biomed Biochim Acta; 1990; 49(7):579-87. PubMed ID: 1704216 [Abstract] [Full Text] [Related]
2. The inhibition of P338 lymphocytic leukemia DNA polymerase alpha activity by cis-diamminedichloroplatinum(II) and related derivatives. Oswald CB, Hall IH. Anticancer Res; 1989; 9(4):915-22. PubMed ID: 2817817 [Abstract] [Full Text] [Related]
3. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line. Mauldin SK, Husain I, Sancar A, Chaney SG. Cancer Res; 1986 Jun; 46(6):2876-82. PubMed ID: 3698013 [Abstract] [Full Text] [Related]
4. Inhibition of DNA synthesis in P388 lymphocytic leukemia cells of BDF1 mice by cis-diamminedichloroplatinum(II) and its derivatives. Oswald CB, Chaney SG, Hall IH. J Pharm Sci; 1990 Oct; 79(10):875-80. PubMed ID: 2280354 [Abstract] [Full Text] [Related]
5. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152). Fujimoto K, Oka T, Morimoto M. Cancer Res; 1987 Mar 15; 47(6):1516-22. PubMed ID: 2434218 [Abstract] [Full Text] [Related]
6. Antineoplastic activity of boron-containing thymidine nucleosides in Tmolt3 leukemic cells. Hall IH, Hall ES, Chi LK, Shaw BR, Sood A, Spielvogel BF. Anticancer Res; 1992 Mar 15; 12(4):1091-7. PubMed ID: 1503401 [Abstract] [Full Text] [Related]
7. Cytotoxicity of 2-ethenyl-2,3-dihydrophthalazine-1,4-diones in murine and human tumor cultured cells. Hall IH, Covington DW, Wheaton JR, Izydore RA, Zhou X. Pharmazie; 2001 Feb 15; 56(2):168-74. PubMed ID: 11234348 [Abstract] [Full Text] [Related]
8. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones. Hall IH, Williams WL, Grippo AA, Lee KH, Holbrook DJ, Chaney SG. Anticancer Res; 1988 Feb 15; 8(1):33-42. PubMed ID: 2895992 [Abstract] [Full Text] [Related]
9. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands. Kido Y, Khokhar AR, al-Baker S, Siddik ZH. Cancer Res; 1993 Oct 01; 53(19):4567-72. PubMed ID: 8402629 [Abstract] [Full Text] [Related]
10. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH, al-Baker S, Thai G, Khokhar AR. Anticancer Drug Des; 1994 Apr 01; 9(2):139-51. PubMed ID: 8166929 [Abstract] [Full Text] [Related]
11. Platinum incorporation and differential effects of cis- and trans-diamminedichloroplatinum(II) on the growth of mouse leukemia P388/D1. Just G, Holler E. Cancer Res; 1989 Dec 15; 49(24 Pt 1):7072-7. PubMed ID: 2582449 [Abstract] [Full Text] [Related]
12. [In vitro biological activity of new platinum(II) and palladium(II) complex compounds]. Malinowska K, Modranka R, Kubiak K, Mrowicka M, Kedziora J, Klimczak A, Rutkowski M. Pol Merkur Lekarski; 2009 Jan 15; 26(151):52-6. PubMed ID: 19391508 [Abstract] [Full Text] [Related]
13. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. O'Dwyer PJ, Moyer JD, Suffness M, Harrison SD, Cysyk R, Hamilton TC, Plowman J. Cancer Res; 1994 Feb 01; 54(3):724-9. PubMed ID: 8306334 [Abstract] [Full Text] [Related]
14. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes. Hrubisko M, Balázová E, Kiss F, Kovácová J, Ujházy V. Neoplasma; 1989 Feb 01; 36(6):651-7. PubMed ID: 2615869 [Abstract] [Full Text] [Related]
15. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA. Knox RJ, Friedlos F, Lydall DA, Roberts JJ. Cancer Res; 1986 Apr 01; 46(4 Pt 2):1972-9. PubMed ID: 3512077 [Abstract] [Full Text] [Related]
16. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents. Hollis LS, Sundquist WI, Burstyn JN, Heiger-Bernays WJ, Bellon SF, Ahmed KJ, Amundsen AR, Stern EW, Lippard SJ. Cancer Res; 1991 Apr 01; 51(7):1866-75. PubMed ID: 2004370 [Abstract] [Full Text] [Related]
17. Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge. Burres NS, Sazesh S, Gunawardana GP, Clement JJ. Cancer Res; 1989 Oct 01; 49(19):5267-74. PubMed ID: 2548717 [Abstract] [Full Text] [Related]
18. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents. Montine TJ, Borch RF. Cancer Res; 1988 Nov 01; 48(21):6017-24. PubMed ID: 2458831 [Abstract] [Full Text] [Related]
19. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy. Sbovata SM, Bettio F, Mozzon M, Bertani R, Venzo A, Benetollo F, Michelin RA, Gandin V, Marzano C. J Med Chem; 2007 Sep 20; 50(19):4775-84. PubMed ID: 17713897 [Abstract] [Full Text] [Related]
20. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo. Herman TS, Teicher BA, Chan V, Collins LS, Kaufmann ME, Loh C. Cancer Res; 1988 May 01; 48(9):2335-41. PubMed ID: 3356001 [Abstract] [Full Text] [Related] Page: [Next] [New Search]